Howard Hughes Medical Institute :: MIT :: The Picower Institute for Learning and Memory

 

Home
In the News
Publications

People

Current Research
Contact Us
Links


Pathophysiology of genetically defined developmental brain disorders


Ongoing projects are addressing the following questions:

• What are the molecular mechanisms that couple mGluR5 to protein synthesis, and do these represent novel therapeutic targets for FX?

• What proteins are overexpressed in FX, and how do they contribute to LTD and pathophysiology of the disease?

• Can adult onset treatments reverse damage caused by altered brain development in fragile X?

• Can a “high content” assay of cultured neurons from the Fmr1 KO mouse be used to screen chemical libraries for novel therapeutics?

• Do other single gene disorders characterized by intellectual disability and autism share the same synaptic pathophysiology as fragile X?  Current efforts are focused on the Tsc2+/- mouse model of tuberous sclerosis, and the MeCP2 null model of Rett syndrome.



Sample of relevant recent papers:


Osterweil EK, Chuang SC, Chubykin AA, Sidorov M, Bianchi R, Wong RK, Bear MF
Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile x syndrome
Neuron. 2013 Jan 23;77(2):243-50


Bhakar AL, Dölen G, Bear MF
The pathophysiology of fragile X (and what it teaches us about synapses)
Annu Rev Neurosci. 2012;35:417-43


Zoghbi HY, Bear MF
Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities
Cold Spring Harb Perspect Biol. 2012 Mar 1;4(3). Review


Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L
Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Neuron. 2012 Apr 12;74(1):49-56


Auerbach BD, Osterweil EK, Bear MF
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Nature. 2011 Nov 23;480(7375):63-68


Krueger DD, Bear MF
Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Annu Rev Med. 2011;62:411-29


Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF
Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2587-92

Osterweil EK, Krueger DD, Reinhold K, Bear MF
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
J Neurosci. 2010 Nov 17;30(46):15616-27


Krueger DD, Osterweil EK, Bear MF
Activation of mGluR5 induces rapid and long-lasting protein kinase D phosphorylation in hippocampal neurons

J Mol Neurosci. 2010 Sep;42(1):1-8. Epub 2010 Feb 23

Auerbach BD, Bear MF
Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis
J Neurophysiol. 2010 Aug;104(2):1047-51


Dölen G, Bear MF
Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome
J Physiol. 2008 Mar 15;586(6):1503-8


Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA, Kidd FL, Sung CC, 
Miyakawa T, Bear MF, Weinberg RJ, Sheng M
Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1
J Neurosci. 2008 Feb 13;28(7):1697-708

Kelleher RJ 3rd, Bear MF
The autistic neuron: troubled translation?
Cell. 2008 Oct 31;135(3):401-6


Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF.
Correction of fragile X syndrome in mice
Neuron. 2007 Dec 20;56(6):955-62